Back to search results

App-Based Support for CPAP Use in Sleep Apnea

This study is looking at how a smartphone app called SleepWell24 can help people with obstructive sleep apnea (OSA) use their CPAP machine more consistently. The app connects with a smart plug and a Fitbit to track CPAP usage and includes weekly questionnaires. The goal is to help people use their CPAP for at least 6 hours a night, 6 nights a week. Researchers will measure how well people adopt CPAP use and how their quality of life changes over about 6 months. You might be able to join if you are an adult (18 or older) who has been newly diagnosed with OSA and speaks English. The study aims to include about 40 participants, balancing for gender and OSA severity. The current recruitment status is unclear.

Study design
This is an interventional study with a planned enrollment of 40 participants. It is not specified if it is randomized or blinded.
What's involved
You will use the SleepWell24 application, which connects to a smart plug and a Fitbit Charge 4. You will also complete weekly questionnaires for approximately 6 months.
Compensation
Not stated in the trial record.
Follow-up
Your CPAP adoption will be measured at approximately 6 months, and your quality of life will be assessed weekly for approximately 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06381115

App-Based Optimization of Long-Term CPAP Adherence and Quality of Life

Recruiting
NAAges 18+InterventionalTreatment
Mayo Clinic
~40 participants
Updated 2026-08-14 on ClinicalTrials.gov
What's tested:SleepWell24 Application

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
CPAP Adoption
Measured over approximately 6 months
+1 more outcome measured

Conditions

Obstructive Sleep Apnea

Explore related trials

Obstructive Sleep Apnea

Where it's being run

2 sites across 2 states
Arizona1
Minnesota1

Study leadership

  • Timothy Morgenthaler, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic

Who to contact

Betty Monari
[email protected]
480-574-2641
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

In both trials of Aim 2, twenty adults (≥18 years) per trial will be recruited who are newly diagnosed with OSA and speak English.
In both trials, we will purposely recruit samples balanced by biological sex and OSA severity (apnea hypopnea index: 5-14 vs. ≥ 15).
Are diagnosed with OSA based on clinical diagnostic testing via laboratory or home-based sleep study;
Own and have the functional and cognitive ability to use an Apple (iOS9 or higher) or Android (4.2 or higher) smartphone with minimal to no assistance;
Are prescribed continuous or auto-titrated CPAP;
Agree to using a smartphone application and wearable wrist sensor; and
Speak and read English.

Exclusion

Unwilling to complete study measures and engage with SleepWell24;
Refuse to not use the Fitbit application during the study trial;
Have any conditions that would impede full participation (e.g., communication or cognitive impairments that limit ability to read and/or follow directions, other acute or severe health, cognitive, or psychological conditions);
Currently participating in other lifestyle programs (e.g. active, formal weight loss program or research study; smoking cessation program, etc.);
Decide to use a different PAP device than ResMed Airsense 10;
Prescribed high-dose benzodiazepines (equivalent to \> 1 mg lorazapam/night);
Daily opioid medication use at night;'
Unwilling to discontinue use of any current wearable sensor for the duration of the trial;
Previous documented history of treatment/referral for claustrophobia;
Previous CPAP use;
Currently engaging in shiftwork defined as night shift or rotating day and night shifts; and
Currently pregnant, trying to conceive, or breastfeeding.

What this trial measures

  • CPAP Adoptionapproximately 6 months

    The Shelly smart plug will be used to monitor the amount of CPAP time usage by the amount of wattage recorded.

  • Change in Quality of Lifebaseline, weekly assessments for approximately 6 months

    As measured by weekly survey asking participants to rate their health based on excellent, very good, good, fair, and poor.